ロード中...
Outcomes of Gleason Score ≤8 among High Risk Prostate Cancer Treated with (125)I Low Dose Rate Brachytherapy Based Multimodal Therapy
PURPOSE: To investigate the role of low dose rate (LDR) brachytherapy-based multimodal therapy in high-risk prostate cancer (PCa) and analyze its optimal indications. MATERIALS AND METHODS: We reviewed the records of 50 high-risk PCa patients [clinical stage ≥T2c, prostate-specific antigen (PSA) >...
保存先:
| 主要な著者: | , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Yonsei University College of Medicine
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3743192/ https://ncbi.nlm.nih.gov/pubmed/23918571 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3349/ymj.2013.54.5.1207 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|